Suppr超能文献

美国左心耳封堵术的适应证及相关院内转归:来自 NCDR LAAO 注册研究的结果。

Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry.

机构信息

Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (U.A.D.).

Center for Outcomes Research and Evaluation Yale New Haven Health Services Corporation, New Haven, CT (Y.W., D.J.F., C.D., J.P.C., J.V.F.).

出版信息

Circ Cardiovasc Qual Outcomes. 2022 Aug;15(8):e008418. doi: 10.1161/CIRCOUTCOMES.121.008418. Epub 2022 Aug 12.

Abstract

BACKGROUND

The Food and Drug Administration approved left atrial appendage occlusion with the Watchman device for patients who are at increased stroke risk and are suitable for oral anticoagulation but who have an appropriate reason to seek a nondrug alternative. These broad criteria raise the question of their interpretation in clinical practice. There is a lack of studies comprehensively evaluating the indications for Watchman implantation among a large series of patients from contemporary, real-world practice in the United States.

METHODS

We used the National Cardiovascular Data Registry Left Atrial Appendage Occlusion Registry to identify Watchman procedures performed between 2016 and 2018. We assessed procedural indications for Watchman implantation in the United States and evaluated the association between procedural indications and in-hospital adverse events.

RESULTS

A total of 38 314 procedures were included. The mean patient age was 76.1±8.1 years, and 58.9% were men. The mean CHADS-VASc score was 4.8±1.5, whereas the mean hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs/alcohol (HAS-BLED) score was 3.0±1.1. Prior stroke or transient ischemic attack was reported in 40.2% and prior bleeding in 70.1%, with gastrointestinal bleeding being most common (41.9%). The most common site-reported procedural indications for Watchman implantation were increased thromboembolic risk (64.8%) and history of major bleed (64.3%), followed by high fall risk (35.5%). Most (71.9%) had ≥2 procedural indications. Patients with high fall risk had increased risk of in-hospital adverse events (adjusted OR, 1.12; =0.025), but no other differences were found in the risk of in-hospital adverse events by procedural indication.

CONCLUSIONS

Among patients in the National Cardiovascular Data Registry Left Atrial Appendage Occlusion Registry, the most common procedural indications for Watchman implantation were increased thromboembolic risk, history of major bleed, and high fall risk. A majority of patients had multiple procedural indications. High fall risk conferred a modestly increased risk of in-hospital adverse events.

摘要

背景

美国食品和药物管理局批准了左心耳封堵术 Watchman 装置,适用于有增加中风风险且适合口服抗凝治疗但有合理理由寻求非药物替代治疗的患者。这些广泛的标准提出了在临床实践中如何解释这些标准的问题。在美国,缺乏在大型真实世界患者系列中全面评估 Watchman 植入适应证的研究。

方法

我们使用国家心血管数据注册左心耳封堵术登记处,确定 2016 年至 2018 年期间进行的 Watchman 手术。我们评估了美国 Watchman 植入的手术适应证,并评估了手术适应证与住院期间不良事件之间的关系。

结果

共纳入 38314 例手术。患者平均年龄为 76.1±8.1 岁,58.9%为男性。平均 CHADS-VASc 评分为 4.8±1.5,而平均高血压、异常肾功能/肝功能、中风、出血史或倾向、不稳定国际标准化比值、老年、药物/酒精(HAS-BLED)评分为 3.0±1.1。40.2%的患者报告有既往卒中或短暂性脑缺血发作,70.1%的患者有既往出血史,最常见的是胃肠道出血(41.9%)。报告的 Watchman 植入最常见的手术适应证是血栓栓塞风险增加(64.8%)和既往大出血史(64.3%),其次是高跌倒风险(35.5%)。大多数患者(71.9%)有≥2 个手术适应证。高跌倒风险的患者发生住院期间不良事件的风险增加(调整后的比值比,1.12;=0.025),但根据手术适应证,住院期间不良事件的风险无其他差异。

结论

在国家心血管数据注册左心耳封堵术登记处的患者中,Watchman 植入最常见的手术适应证是血栓栓塞风险增加、既往大出血史和高跌倒风险。大多数患者有多个手术适应证。高跌倒风险略增加住院期间不良事件的风险。

相似文献

2
The NCDR Left Atrial Appendage Occlusion Registry.NCDR 左心耳封堵器械注册研究。
J Am Coll Cardiol. 2020 Apr 7;75(13):1503-1518. doi: 10.1016/j.jacc.2019.12.040.
5
Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion.WATCHMAN 左心耳封堵术的操作量和结果。
Circ Cardiovasc Interv. 2024 Jun;17(6):e013466. doi: 10.1161/CIRCINTERVENTIONS.123.013466. Epub 2024 Jun 18.

引用本文的文献

2
Left Atrial Appendage Occlusion: Expanding Indications and New Developments.左心耳封堵术:适应证拓展与新进展
Struct Heart. 2024 Aug 3;9(1):100354. doi: 10.1016/j.shj.2024.100354. eCollection 2025 Jan.
4
10
Transcatheter Left Atrial Appendage Closure.经导管左心耳封堵术。
Methodist Debakey Cardiovasc J. 2023 May 16;19(3):67-77. doi: 10.14797/mdcvj.1215. eCollection 2023.

本文引用的文献

1
The NCDR Left Atrial Appendage Occlusion Registry.NCDR 左心耳封堵器械注册研究。
J Am Coll Cardiol. 2020 Apr 7;75(13):1503-1518. doi: 10.1016/j.jacc.2019.12.040.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验